Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Savient Pharmaceuticals, Inc.
(NQ:
SVNT
)
0.5600
USD
-0.0100 (-1.75%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
0.5600
Bid (Size)
0.5450 (68500)
Ask (Size)
0.5600 (1000)
Prev. Close
0.5700
Today's Range
0.5110 - 0.5988
52wk Range
0.4831 - 2.950
Shares Outstanding
73,615,573
Dividend Yield
N/A
Top News
More News
William Blair Downgrades Savient Pharmaceuticals (SVNT) to Market Perform
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349693 for the full story.
Read More
from
StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 05/15: (MFLR) (CHCI) (NYNY) Higher; (SVNT) (XONE) (WTT) Lower
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8341794 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Savient Pharmaceuticals Down 14.1%, Shares Slide into the Red (SVNT)
May 15, 2013
from
Comtex SmarTrend® News Briefs
Savient Pharmaceuticals (SVNT) Posts Q1 Loss of 34c/Share
May 15, 2013
from
StreetInsider.com News Articles
Savient Pharmaceuticals Reports First Quarter 2013 Financial Results
May 15, 2013
from
PR Newswire
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 13, 2013
from
GlobeNewswire News Releases
First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting
May 01, 2013
from
Business Wire News Releases
First Manhattan Comments on Addition to Vivus’ Board of Directors
May 01, 2013
from
Business Wire News Releases
Investors look to Lighten Up on Shares of Savient Pharmaceuticals, Shares Down 10.7% (SVNT)
March 19, 2013
from
Comtex SmarTrend® News Briefs
Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 39c/Share
March 19, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.